Forté Pharma Ibérica, S.L.U. Sustainability Profile
Forté Pharma Ibérica, S.L.U., a prominent player in the health and wellness industry, is headquartered in Spain and operates extensively across the Iberian Peninsula. Founded in 2004, the company has established itself as a leader in dietary supplements and innovative health solutions, focusing on areas such as weight management, energy enhancement, and overall well-being. With a diverse portfolio of unique products, Forté Pharma is renowned for its commitment to quality and efficacy, utilising advanced formulations that cater to the specific needs of consumers. The company has achieved significant market recognition, positioning itself as a trusted brand in the competitive health sector. Through continuous research and development, Forté Pharma Ibérica remains dedicated to enhancing the health of its customers while maintaining a strong presence in the European market.
DitchCarbon Score
How does Forté Pharma Ibérica, S.L.U.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Forté Pharma Ibérica, S.L.U.'s score of 25 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Forté Pharma Ibérica, S.L.U., headquartered in Spain, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Laboratorio Reig Jofre, S.A., which may influence its climate commitments and performance metrics. As part of its corporate family, Forté Pharma Ibérica may inherit sustainability initiatives and targets from Laboratorio Reig Jofre, S.A. However, no specific reduction targets or climate pledges have been documented for Forté Pharma Ibérica itself. The lack of reported emissions data suggests that the company may still be in the early stages of formalising its climate strategy or reporting practices. In the broader context, companies in the pharmaceutical sector are increasingly focusing on sustainability and carbon reduction, often aligning with industry standards such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). Forté Pharma Ibérica's commitment to these initiatives may be reflected in the practices of its parent company, although specific details are not available at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 2,829,000 | 0,000,000 |
| Scope 2 | 4,614,000 | 0,000 |
| Scope 3 | 13,339,000 | 00,000,000 |
How Carbon Intensive is Forté Pharma Ibérica, S.L.U.'s Industry?
How Carbon Intensive is Forté Pharma Ibérica, S.L.U.'s Location?
Forté Pharma Ibérica, S.L.U.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Forté Pharma Ibérica, S.L.U. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.